Literature DB >> 916618

[Hemodynamic effects of sar1-ala8-angiotensin in patients with renovascular hypertension (author's transl)].

T Philipp, H Zschierdrich, A Distler.   

Abstract

In 7 hypertensive patients with renal artery stenosis and in 1 patient with hypertension and unilateral pyelonephritic nephrophthisi the influence of the angiotensin II antagonist, saralasin on systemic hemodynamics was studied. In the patients with normal renin infusion of saralasin produced an increase in total peripheral resistance, in patients with elevated renin a decrease in peripheral resistance was observed. In 3 patients who had extremely high renin levels while under sodium saralasin produced a dangerous drop in blood pressure concomitant with a marked decrease in cardiac output and in central venous pressure, heart rate remained unchanged or increased just slightly. The findings suggest that in patients with high plasma renin peripheral resistance, venous tone, venous retrun, and cardiac output are to a large extent controlled by circulating angiotensin II.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 916618     DOI: 10.1007/bf01478829

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  7 in total

1.  Hemodynamic and metabolic effects of angiotensin II during rest and exercise in normal healthy subjects.

Authors:  W P JOHNSON; R A BRUCE
Journal:  Am Heart J       Date:  1962-02       Impact factor: 4.749

2.  Agonist and antagonist effects of Sar1-ala8--angiotensin II in salt-loaded and salt-depleted normal man.

Authors:  G A MacGregor; P M Dawes
Journal:  Br J Clin Pharmacol       Date:  1976-06       Impact factor: 4.335

3.  Studies on the mechanism of aldosterone-induced hypertension in man.

Authors:  A Distler; H J Just; T Philipp
Journal:  Clin Sci Mol Med       Date:  1973-12

4.  Infusion of angiotensin-II analogue in two patients with unilateral renovascular hypertension.

Authors:  A J Donker; F H Leenen
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

5.  Use of an angiotensin II antagonist (saralasin) in the recognition of "angiotensinogenic" hypertension;.

Authors:  D H Streeten; G H Anderson; J M Freiberg; T G Dalakos
Journal:  N Engl J Med       Date:  1975-03-27       Impact factor: 91.245

6.  Blockade and stimulation of renal, adrenal, and vascular angiotensin II receptors with 1-Sar, 8-Ala angiotensin II in normal man.

Authors:  N K Hollenberg; G H Williams; B Burger; I Ishikawa; D F Adams
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

7.  Renin dependency of blood-pressure. Analysis by angiotensin II antagonist P113 in hypertensive patients treated with salt depletion and propranolol.

Authors:  G G Geyskes; P Boer; J Vos; E J Dorhout Mees
Journal:  Lancet       Date:  1976-05-15       Impact factor: 79.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.